All Regarding Luveris
Luveris is acknowledged for being the primary recombinant human luteinizing hormone and has been widely permitted by all fertility physicians from all over the globe. Luveris is widely employed recently in America wherein it stimulates follicular development for women having LH deficiency that falls below 1.2 IU/L.
It should be known to all that LH is an important hormone created by the pituitary or master gland. This gland plays a very imperative role in our reproductive system both for men and women. Luveris is made out of the human DNA using high technologies. It only means that the drug is the synthetic form of the human DNA.
If you are willing to use the drug, you must primarily seek advice from your trusted medical doctor that specializes in fertility concerns. The adverse effects are the following: multiple pregnancies, lung problems, and OHSS or Ovarian HyperStimulation Syndrome. This drug is contraindicated to ladies who have history of allergic reactions to human LH products, ovaries that are nonfunctioning, thyroid and adrenal disorders, cancer in the reproductive organs, tumors particularly in pituitary gland or brain, profuse or abnormal vaginal bleeding, ovarian cyst, and pregnant or lactating ladies.
General side effects may include: headache, ovarian cyst, OHSS, abdominal discomfort, and headache.
Luveris is administered through injection with the combination of Gonal f or Follitropin alfa. It is very vital for patients to be informed with regards to the longevity of the treatment process as well as the need to monitor effects of the drug.
Before beginning the Luveris treatment process, it is essential to rule out pregnancy as well as an endocrine test and gynecologic exam must be done initially. Assessment will also include the women’s potential to become fertile in the near future.
This drug is usually given via subcutaneous injection. The recommended dosage is 75 IU with 150 IU of Gonal -f. Both drugs need to be injected independently. It should be injected every day according to physician’s order or until there is adequate development in the follicles that is detected via ultrasound or via blood test. It is not recommended for the therapy to exceed more than 14 days unless the woman show signs of development in her follicles.
To learn more about luveris kindly check out our website!
Processing your request, Please wait....
